Citadel Advisors’s Sanofi SNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $71.7M | Buy |
1,487,970
+235,434
| +19% | +$11M | 0.01% | 1058 |
|
|
2025
Q4 | $60.7M | Buy |
1,252,536
+481,099
| +62% | +$23.8M | 0.01% | 1252 |
|
|
2025
Q3 | $36.4M | Buy |
771,437
+553,117
| +253% | +$26.7M | 0.01% | 1689 |
|
|
2025
Q2 | $10.5M | Buy |
218,320
+166,487
| +321% | +$8.51M | ﹤0.01% | 2949 |
|
|
2025
Q1 | $2.87M | Sell |
51,833
-32,127
| -38% | -$1.74M | ﹤0.01% | 4841 |
|
|
2024
Q4 | $4.05M | Sell |
83,960
-91,633
| -52% | -$4.66M | ﹤0.01% | 4315 |
|
|
2024
Q3 | $10.1M | Buy |
175,593
+50,150
| +40% | +$2.71M | ﹤0.01% | 2873 |
|
|
2024
Q2 | $6.09M | Buy |
125,443
+72,582
| +137% | +$3.5M | ﹤0.01% | 3443 |
|
|
2024
Q1 | $2.57M | Sell |
52,861
-70
| -0.1% | -$3.42K | ﹤0.01% | 5045 |
|
|
2023
Q4 | $2.63M | Buy |
52,931
+39,232
| +286% | +$1.92M | ﹤0.01% | 4879 |
|
|
2023
Q3 | $735K | Buy |
13,699
+13,508
| +7,072% | +$720K | ﹤0.01% | 7238 |
|
|
2023
Q2 | $10.3K | Sell |
191
-89,812
| -100% | -$4.83M | ﹤0.01% | 13213 |
|
|
2023
Q1 | $4.9M | Buy |
90,003
+28,111
| +45% | +$1.37M | ﹤0.01% | 3855 |
|
|
2022
Q4 | $3M | Sell |
61,892
-333,233
| -84% | -$14.6M | ﹤0.01% | 4750 |
|
|
2022
Q3 | $15M | Buy |
395,125
+236,347
| +149% | +$10.5M | ﹤0.01% | 2220 |
|
|
2022
Q2 | $7.94M | Buy |
158,778
+77,093
| +94% | +$4.09M | ﹤0.01% | 2984 |
|
|
2022
Q1 | $4.19M | Sell |
81,685
-81,474
| -50% | -$4.21M | ﹤0.01% | 4525 |
|
|
2021
Q4 | $8.17M | Buy |
163,159
+94,472
| +138% | +$4.67M | ﹤0.01% | 3408 |
|
|
2021
Q3 | $3.31M | Sell |
68,687
-128,097
| -65% | -$6.51M | ﹤0.01% | 5149 |
|
|
2021
Q2 | $10.4M | Sell |
196,784
-131,616
| -40% | -$6.87M | ﹤0.01% | 3011 |
|
|
2021
Q1 | $16.2M | Buy |
328,400
+888
| +0.3% | +$42.7K | ﹤0.01% | 2241 |
|
|
2020
Q4 | $15.9M | Sell |
327,512
-130,713
| -29% | -$6.45M | ﹤0.01% | 2060 |
|
|
2020
Q3 | $23M | Buy |
458,225
+100,874
| +28% | +$5.19M | 0.01% | 1452 |
|
|
2020
Q2 | $18.2M | Buy |
357,351
+13,885
| +4% | +$675K | 0.01% | 1582 |
|
|
2020
Q1 | $15M | Buy |
343,466
+36,337
| +12% | +$1.74M | 0.01% | 1479 |
|
|
2019
Q4 | $15.4M | Buy |
307,129
+126,175
| +70% | +$5.91M | 0.01% | 1742 |
|
|
2019
Q3 | $8.38M | Buy |
+180,954
| New | +$7.8M | ﹤0.01% | 2431 |
|
|
2018
Q3 | – | Sell |
-9,671
| Closed | -$413K | – | 9658 |
|
|
2018
Q2 | $387K | Sell |
9,671
-24,549
| -72% | -$966K | ﹤0.01% | 6789 |
|
|
2018
Q1 | $1.37M | Sell |
34,220
-11,737
| -26% | -$488K | ﹤0.01% | 4319 |
|
|
2017
Q4 | $1.98M | Buy |
+45,957
| New | +$2.12M | ﹤0.01% | 3656 |
|
|
2017
Q3 | – | Sell |
-28,552
| Closed | -$1.38M | – | 8008 |
|
|
2017
Q2 | $1.37M | Buy |
+28,552
| New | +$1.36M | ﹤0.01% | 3656 |
|
|
2017
Q1 | – | Sell |
-18,710
| Closed | -$794K | – | 7994 |
|
|
2016
Q4 | $757K | Buy |
+18,710
| New | +$737K | ﹤0.01% | 4256 |
|
|
2016
Q2 | – | Sell |
-56,533
| Closed | -$2.32M | – | 7355 |
|
|
2016
Q1 | $2.27M | Buy |
56,533
+19,366
| +52% | +$778K | ﹤0.01% | 2511 |
|
|
2015
Q4 | $1.58M | Buy |
37,167
+16,568
| +80% | +$762K | ﹤0.01% | 3007 |
|
|
2015
Q3 | $978K | Buy |
+20,599
| New | +$1.05M | ﹤0.01% | 3849 |
|
|
2014
Q4 | – | Sell |
-5,300
| Closed | -$299K | – | 8712 |
|
|
2014
Q3 | $299K | Buy |
+5,300
| New | +$285K | ﹤0.01% | 5263 |
|
|
2013
Q4 | – | Sell |
-24,594
| Closed | -$1.25M | – | 7155 |
|
|
2013
Q3 | $1.25M | Sell |
24,594
-10,483
| -30% | -$533K | ﹤0.01% | 2873 |
|
|
2013
Q2 | $1.81M | Buy |
+35,077
| New | +$1.87M | ﹤0.01% | 2596 |
|
Other funds holding SNY
MIP
Citadel Advisors's SNY Position: Q1 2026 in Review
Citadel Advisors increased its Sanofi (SNY) stake by 19% in Q1 2026, buying an estimated $11M and bringing the position to 1,487,970 shares worth $71.7M. The position accounts for 0.01% of the portfolio, ranked #1058.
Citadel Advisors first reported a position in SNY in Q2 2013 and has held it in 38 quarters since. 737 funds tracked by Wall St. Rank hold SNY as of Q1 2026.
- Citadel Advisors held 1,487,970 shares of Sanofi worth $71.7M as of Q1 2026.
- Citadel Advisors bought 235,434 Sanofi shares in Q1 2026, an estimated $11M.
- Sanofi made up 0.01% of Citadel Advisors's portfolio in Q1 2026, its #1058 holding.
- Citadel Advisors first reported a position in Sanofi in Q2 2013 and has held it in 38 quarters since.
- 737 funds tracked by Wall St. Rank held Sanofi as of Q1 2026.
Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.